EXTRANODAL DISEASE IS ASSOCIATED WITH SHORTER PROGRESSION‐FREE SURVIVAL AFTER CD19‐CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Open Access
- 17 June 2021
- journal article
- abstracts
- Published by Wiley in Hematological Oncology
- Vol. 39 (S2)